SNP and gene associations use P < 10⁻¹⁰. Change threshold · Counts cover features with indexed GWAS data; — means unavailable.

GeneAssociated metabolitesResearch resources

GENE DETAIL · Glycine max

Glyma.08G122600

Description hypothetical protein

Gene interval Chr08:9445153–9450502 (+), Wm82.a2.v1 · 1-based inclusive

Arabidopsis ortholog NA

Genome context

Explore gene–feature relationships using Overlap or Within ±5 kb. Scope definitions

Explore research resources ↓
Associated metabolite features513Overlap
Maximum supporting SNP records2
Features with ≥2 supporting SNP records29

Supporting SNP records satisfy P < 10⁻¹⁰ and the selected positional scope. Counts cover the 30345 features with indexed GWAS data.

Additional descriptive statistic

Mean supporting SNP records per associated feature: 1.0565.

Research resources

Follow this gene identifier to compare annotations, examine protein function and find supporting literature.

These links search the displayed identifier. Check the organism, genome assembly and evidence in the destination record.

Compare gene models, expression and reported orthologs

SoyBase gene-name translator ↗SoyBase expression resources ↗Legume Information System ↗

Use expression and ortholog evidence to develop a testable hypothesis. The linked resources do not establish the function of this soybean gene in the measured samples.

Associated metabolites

Browse associated features and open their GWAS evidence or compound candidates.

513 matching features · page 1 of 52

Metabolite IDCandidate annotationDeionized mass (Da)Supporting SNP recordsMinimum P
P00419 2-Iminobutanoate 101.0471 29.195e-13
P01586 No candidate annotation 466.0550 22.097e-13
P03834 No candidate annotation 120.0280 29.864e-12
P08885 (5R,6S)-5,6-Epoxy-7-megastigmen-9-one 208.1431 23.117e-14
P10463 Nitrazine 233.1231 21.555e-12
P10528 Etoperidone 377.1934 27.274e-13
P10815 (-)-Acaterin 226.1559 23.902e-11
P13849 Cyclohexanol 100.0874 21.654e-13
P13879 Furametpyr 333.1246 25.874e-14
P13981 Heitziamide B 263.1155 27.2e-12